Surgery Partners
SGRY
Market cap $2.98B

23.48 USD

-0.27

1.14%

At close Apr 1, 4:00 PM EDT

After hours

23.48

+0.00

0.00%

1 day

-1.14%

5 days

-3.26%

1 month

-2.17%

3 months

10.29%

6 months

-27.73%

Year to date

10.29%

1 year

-18.70%

5 years

344.70%

10 years

29.65%

About: Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.

Employees: 13,500

Healthcare General Medical & Surgical Hospitals

0

Funds holding %

of 7,398 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

25% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 55

12% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 33

3.46% more ownership

Funds ownership: 107.95% [Q3] → 111.41% (+3.46%) [Q4]

0% more funds holding

Funds holding: 182 [Q3] → 182 (+0) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 4 (+0) [Q4]

32% less capital invested

Capital invested by funds: $4.42B [Q3] → $3B (-$1.43B) [Q4]

39% less call options, than puts

Call options by funds: $9.06M | Put options by funds: $14.8M

See Fund Rankings

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$33

41%

upside

Avg. target

$34

45%

upside

High target

$35

49%

upside

2 analyst ratings

2 positive

100%

0 neutral

0%

0 negative

0%

RBC Capital Ben Hendrix 41% 1-year accuracy 27 / 66 met price target	49%upside $35	Outperform Reiterated	25 Mar 2025
Macquarie Tao Qiu 45% 1-year accuracy 9 / 20 met price target	41%upside $33	Outperform Maintained	11 Mar 2025

See Analyst Rankings

Financial journalist opinion

Surgery Partners, Inc. (SGRY) Q4 2024 Earnings Call Transcript

Surgery Partners, Inc. (NASDAQ:SGRY ) Q4 2024 Earnings Conference Call March 3, 2025 8:30 AM ET Company Participants Eric Evans - Chief Executive Officer Dave Doherty - Executive Vice President and Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Benjamin Rossi - JPMorgan Chase Joanna Gajuk - Bank of America A.J. Rice - Credit Suisse Tao Qiu - Macquarie Research Andrew Mok - Barclays Matthew Gillmor - KeyBanc Capital Markets Whit Mayo - SVB Leerink Sarah James - Cantor Fitzgerald Operator Greetings.

Surgery Partners, Inc. (SGRY) Q4 2024 Earnings Call Transcript

Zacks Investment Research

Surgery Partners (SGRY) Q4 Earnings and Revenues Surpass Estimates

Surgery Partners (SGRY) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.44 per share a year ago.

Surgery Partners (SGRY) Q4 Earnings and Revenues Surpass Estimates

These 2 REITs Make Great Buys For Income Investors

REITs have surged in value. But opportunities still remain for income-oriented investors. I present two REITs to buy today.

These 2 REITs Make Great Buys For Income Investors

Surgery Partners, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call Details

BRENTWOOD, Tenn., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2024 results before the market opens on Monday, March 3, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time).

Surgery Partners, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call Details

Japan In The Spotlight; Blockchain In AI's Shadow

As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. The value of private equity investment in Japan jumped nearly 41% over the prior-year total in 2024, far outpacing the 25% year-over-year gain in global private equity deal value, according to S&P Global Market Intelligence data.

Japan In The Spotlight; Blockchain In AI's Shadow

Zacks Investment Research

Surgery Partners (SGRY) Surges 21.2%: Is This an Indication of Further Gains?

Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Surgery Partners (SGRY) Surges 21.2%: Is This an Indication of Further Gains?

Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital

BRENTWOOD, Tenn., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced that its Board of Directors (the “Board”) received a non-binding proposal, dated January 27, 2025, from Bain Capital Private Equity, LP (“Bain Capital”) to acquire all of the outstanding shares of Surgery Partners not already owned by Bain Capital for a cash consideration of $25.75 per share (the “Bain Capital Proposal”). Bain Capital and its affiliates own approximately 39% of the Company's outstanding common stock, based on the Schedule 13D/A filing dated January 28, 2025.

Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital

Bain Capital proposes to acquire remaining shares of Surgery Partners

Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it does not already own for $25.75 apiece, a filing showed on Tuesday.

Bain Capital proposes to acquire remaining shares of Surgery Partners

Surgery Partners, Inc. Names Laura L. Forese, MD to Board of Directors

BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese's appointment, which is effective January 10, 2025, will increase the size of Surgery Partners' Board to eleven members.

Surgery Partners, Inc. Names Laura L. Forese, MD to Board of Directors

Surgery Partners, Inc. (SGRY) Q3 2024 Earnings Call Transcript

Surgery Partners, Inc. (NASDAQ:SGRY ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Jack Slevin - Jefferies Joanna Gajuk - Bank of America A.J. Rice - UBS Andrew Mok - Barclays Tao Qiu - Stifel Sarah James - Cantor Fitzgerald Bill Sutherland - The Benchmark Company Benjamin Rossi - JPMorgan Will Spivack - TD Cowen Operator Greetings, and welcome to the Surgery Partners Third Quarter 2024 Earnings Call.

Surgery Partners, Inc. (SGRY) Q3 2024 Earnings Call Transcript

See News Rankings

Charts implemented using Lightweight Charts™